Specific NF-κB blockade selectively inhibits tumour necrosis factor- α-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells

Immunology

Volumn 95, Issue 4, 1998, Pages 537-543

  Jobin, C ^a   Morteau, O ^a,b   Han, D S ^a   Sartor, R Balfour ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; TUMOR NECROSIS FACTOR ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOENZYME; MEMBRANE PROTEIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PTGS1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN;

ARACHIDONIC ACID METABOLISM; ARTICLE; COLON MUCOSA; DIGESTIVE SYSTEM INFLAMMATION; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADENOVIRUS; CELL STRAIN HT29; DRUG EFFECT; GENE VECTOR; GENETICS; METABOLISM; PHYSIOLOGY; STIMULATION;

ADENOVIRIDAE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION REGULATION; GENETIC VECTORS; HT29 CELLS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; NF-KAPPA B; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STIMULATION, CHEMICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031593824     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00646.x     Document Type: Article

References (44)

1. NEEDLEMAN P., TURK J., JAKSCHIK B.A., MORRISON A.R. & LEFKOWITH J.B. (1986) Arachidonic acid metabolism. Annu Rev Biochem 55, 69.
2. LEWIS R.A., AUSTEN K.F. & SOBERMAN R.J. (1990) Leukotrienes and other products of 5-lipoxygenase pathway. N Engl J Med 323, 645.
3. XIE W., CHIPMAN J.G., ROBERTSON D.L., ERIKSON R.L. & SIMMONS D.L. (1991) Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88, 2692.
4. VANE, J.R., MITCHELL, J.A., APPLETON I. et al. (1994) Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation. Proc Natl Acad Sci USA 91, 2046.
5. MASFERRER J.L., ZWEIFEL B.S., MANNING P.T.Y. et al. (1994) Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 91, 3228.
6. SEIBERT K., ZHANG Y., LEAHY K. et al. (1994) Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 91, 12013.
7. CHAN C.C., BOYEE S., BRIBEAU C. et al. (1995) Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal antiinflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharmacol Exp Ther 274, 1531.
8. COHN S.M., SCHLOEMANN S., TESSNER T., SEIBERT K. & STENSON W.F. (1997) Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J Clin Invest 99, 1367.
9. SHENG H., SHAO J., HOOTON E.B., TSUJII M., DUBOIS R.N. & BEAUCHAMP R.D. (1997) Cyclooxygenase-2 induction and transforming growth factor-β growth inhibition in rats intestinal epithelial cells. Cell Growth and Differentiation 8, 463.
10. 2α production. J Clin Invest 100, 296.
11. GUSTAFSON-SWARD C., LILJA I., SJODAHL R. & TAGESSON C. (1995) Cytosolic phospholipase A2 and cyclooxygenase-2 mediate release and metabolism of arachidonic acid in lumor necrosis factor α-primed cultured intestinal epithelial cells (INT 407). Scand J Gastroenterol 30, 1000.
12. GRISWOLD D.E. & ADAMS J.L. (1996) Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rational for selective inhibition and progress to date. Med Res Rev 16, 181.
13. BARNES P.J. & KARIN M. (1997) Nuclear Factor-κB, a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336, 1066.
14. BAEUERLE P.A. & HENKLE T. (1994) Function and activation of NF-κB in the immune system. Annu Rev Immunol 12, 141.
15. BALDWIN A.S. (1996) The NF-κB and IκB proteins: new discoveries and insight. Annu Rev Immunol 14, 649.
16. JOBIN C., HASKILL S., MAYER L., PANJA A. & SARTOR R.B. (1997) Evidence for an altered regulation of IκBα degradation in human colonic epithelial cells. J Immunol 158, 226.
17. JOBIN C., HELLERBRAND C., LICATO L.L., BRENNER D.A. & SARTOR R.B. (1998) NF-κB mediates cytokine-induced expression of ICAM-1 in IEC-6 cells, a process blocked by proteasome inhibitors. Gut 42, 779.
18. HASKILI S., BEG A.A., TOMPKINS S.M. et al. (1991) Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65, 1281.
19. DIDONATO J.A., HAYAKAWA M., ROTHWARF D., ZANDI E. & KARIN M. (1997) A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388, 548.
20. MERCURIO F., ZHU H., MURRAY B.W. et al. (1997) IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278, 860.
21. STANCOVSKI I. & BALTIMORE D. (1997) NF-κB activation: the IκB kinase revealed? Cell 91, 299.
22. VERMA I.M. & STEVENSON J. (1997) IκB kinase, beginning, not the end. Proc Natl Acad Sci USA 94, 11758.
23. WORONICZ, J.D., GAO X., CAO Z., ROTHE M. & GOEDDEL D.V. (1997) IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278, 866.
24. ZANDI E., ROTHWARF D.M., BELHASE M., HAYAKAMA M. & KARIN M. (1997) The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91, 243.
25. JOBIN C., PANJA A., HELLERBRAND C. et al. (1998) Inhibition of proinflammalory molecule production by adenovirus-mediated expression of an NF-κB super-repressor in human intestinal epithelial cells. J Immunol 160, 410.
26. GUSTAFFSON-SVARD C., LILJA I., HALLBOOK O. & SJODAHL R. (1996) Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats. Gut 38, 79.
27. JOBIN C. & SARTOR R.B. (1998) Altered IκB/NF-κB signaling pathway in HT-29 cells, an intestinal epithelial cell line. FASEB J 12, A269.
28. D'ACQUISTO F., IUVONE T., ROMBOLÀ L., SAUTEBIN L., DI ROSA M. & CARNUCCIO R. (1997) Involvement of NF-κB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett 418, 175.
29. NEWTON R., KUTTER L.M.E., BERGMANN M., ADCOCK I.M. & BARNES P.J. (1997) Evidence for involvement of NF-κB in the transcriptional control of COX-2 gene expression by IL-1β. Biochem Biophys Res Commun 237, 28.
30. KAUFMANN H.J. & TAUBIN H.L. (1987) Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med 107, 513.
31. SOLL, A.H., WEINSTEIN W.M., KURATA J. & MCCARTHY D. (1991) Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med 114, 307.
32. KNUDSEN P.J., DINARELLO C.A. & STROM T.B. (1986) Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol 137, 3189.
33. MARCINKIEWICZ J. (1991) In vivo cytokine release by activated murine peritoneal macrophages: role of prostaglandins in the differential regulation of tumor necrosis factor α, interleukin 1 and interleukin 6. Cytokine 3, 327.
34. 2 before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation. Gastroenterology 96, 1290.
35. FEDORAK R.N., EMPEY L.R., MACARTHUR C. & JEWELL L.D. (1990) Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats. Gastroenterology 98, 615.
36. YAMADA T., DEITCH E., SPECIAN R.D., PERRY M.A., SARTOR R.B. & GRISHAM M.B. (1993) Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 17, 641.
37. WALLACE J.L., KEENAN C.M., GALE D. & SHOUPE T.S. (1992) Exacerbation of experimental colitis by NSAIDs is not related to elevated leukotriene B4 synthesis. Gastroenterology 102, 8.
38. DUBOIS R.N., EBERHART C.E. & WILLIAMS C.S. (1996) Introduction to eicosanoids and the gastroenteric tract. Gastroenterol Clin N 25, 267.
39. LANGENBACH R., MORHAM S.G., TIANO H.F. et al. (1995) Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83, 483.
40. MORHAM S.G., LANGENBACH R., LOFTIN C.D. et al. (1995) Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83, 473.
41. MORTEAU O., MORHAM S.G., SELLON R., VOROBIOV J., SMITHIES O. & SARTOR R.B. (1997) Genetic deficiency in cyclooxygenase-2 but not in cyclooxygenase-1 exacerbates dextran sodium sulfate-induced acute colitis in mice. Gastroenterology 122, A 1046.
42. REUTER B.K., ASFAHA S., BURET A., SHARKEY K.A. & WALLACE J.L. (1996) Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest 98, 2076.
43. HOGABOAM C.M., VALLANCE B.A., KUMAR A. et al. (1997) Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease. J Clin Invest 100, 2766.
44. BROWN G.R., THIELE D.L., SILVA M. & BEUTLER B. (1997) Adenoviral vectors given intravenously to immunocompromised mice yield stable transduction of colonic epithelium. Gastroenterology 112, 1586.